Quantcast

Latest Insulin therapy Stories

2014-02-11 08:30:24

Research advances in novel pathways produce innovative antidiabetic drugs, which will pave the way for successful market penetration LONDON, Feb. 11, 2014 /PRNewswire/ -- Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million people have been diagnosed with diabetes in Europe in 2012, and this number is expected to rise to 64 million by 2030. A recent research by Frost &...

2014-02-07 13:00:08

Insulin use to treat type 2 diabetes trebles over 20 years "Understanding the pattern of insulin use is limited by a lack of data characterizing the prevalence of insulin use in the UK," according to Craig Currie, Professor of Applied Pharmacoepidemiology at Cardiff University's School of Medicine, who led the study alongside colleagues from the University of Bristol. "Given the limitations, our study sought to calculate – for the first time – the best possible estimate of the rates...

2014-01-31 12:25:16

INDIANAPOLIS, Jan. 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has provided the following statement regarding a lawsuit filed by Sanofi in the United States District Court for the District of Delaware alleging patent infringement with respect to LY2963016, a new insulin glargine product for which Lilly is currently seeking approval from the U.S. Food and Drug Administration (FDA). "Lilly respects the intellectual property of others and does not believe the...

2014-01-22 23:21:43

London, Ontario-based Sernova Corp., is developing a better way to treat the disease involving the replacement of lost pancreatic islets, whose function is to read blood sugar levels and release insulin into the blood, normalizing blood sugar levels. London, ON (PRWEB) January 22, 2014 Imagine there is a person with diabetes who must focus on measuring their blood sugar levels almost constantly followed by injection of insulin multiple times each day or monitoring their insulin pump...

2014-01-08 08:28:16

HORW, Switzerland, Jan. 8, 2014 /PRNewswire/ -- CeQur(®) SA, a leader in simple insulin infusion for people with type 2 diabetes, today announced that the company has been invited to present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco. CeQur management is scheduled to present an overview of the company at the Westin St. Francis Hotel on Wednesday, 15 January, 2014 at 7:30 a.m. PT. The Need for Simple Insulin InfusionThere are currently more than 11 million...

2014-01-06 10:00:54

Researchers from the University of Illinois at Chicago College of Medicine have found that dysfunction in a single gene in mice causes fasting hyperglycemia, one of the major symptoms of type 2 diabetes. Their findings were reported online in the journal Diabetes. If a gene called MADD is not functioning properly, insulin is not released into the bloodstream to regulate blood sugar levels, says Bellur S. Prabhakar, professor and head of microbiology and immunology at UIC and lead author of...

2014-01-06 08:25:03

EDGEWATER, N.J., Jan. 6, 2014 /PRNewswire/ -- DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy. DV-0100 is proprietary, novel and safe. The therapy halt's the body's autoimmune reaction against the pancreatic islet cells which are responsible for producing insulin, thus allowing them to produce insulin normally and...

2013-11-21 23:20:21

Reportbuyer.com just published a new market research report: Analysis of the Global Type 2 Diabetes Therapeutics Market. London (PRWEB) November 21, 2013 Market Opportunities for Differentiated Therapeutics Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and...

Nanotechnology-based Technique May Help Diabetics Avoid The Needle
2013-11-21 11:12:29

North Carolina State University A new nanotechnology-based technique for regulating blood sugar in diabetics may give patients the ability to release insulin painlessly using a small ultrasound device, allowing them to go days between injections – rather than using needles to give themselves multiple insulin injections each day. The technique was developed by researchers at North Carolina State University and the University of North Carolina at Chapel Hill. “This is hopefully a big...


Latest Insulin therapy Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.